REGENXBIO (RGNX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
REGENXBIO Inc. (RGNX)
Last regenxbio inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.regenxbio.com
Company Research
Source: Yahoo! Finance
Image source: The Motley Fool. DATE Thursday, March 5, 2026 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Curran Simpson Chief Medical Officer — Steve Pakola Chief Financial Officer — Mitchell Chan Full Conference Call Transcript Patrick Christmas: Good morning, and thank you for joining us today. Earlier this morning, REGENXBIO Inc. released financial and operating results for the fourth quarter and year ending 12/31/2025. The press release is available on our website at www.regenxbio.com. Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted and can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend, and other words of similar meaning. Any such forward-looking statements a
Show less
Read more
Impact Snapshot
Event Time:
RGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGNX alerts
High impacting REGENXBIO Inc. news events
Weekly update
A roundup of the hottest topics
RGNX
News
- Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. InvestorsGlobeNewswire
- REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights [Yahoo! Finance]Yahoo! Finance
- Regenxbio GAAP EPS of -$1.30 misses by $0.36, revenue of $30.34M misses by $15.14M [Seeking Alpha]Seeking Alpha
- REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational HighlightsPR Newswire
RGNX
Earnings
- 3/5/26 - Miss
RGNX
Sec Filings
- 3/5/26 - Form 8-K
- 2/12/26 - Form 424B5
- 2/10/26 - Form 8-K
- RGNX's page on the SEC website